Marc Winterhoff is the interim Chief Executive Officer of Lucid Motors, the Newark, California luxury EV maker behind the Air sedan and Gravity SUV. A German-trained electrical engineer who spent decades advising automakers at Roland Berger and Arthur D. Little, he joined Lucid as COO in December 2023 and was elevated to interim CEO in February 2025 after founder Peter Rawlinson stepped aside. He has steered the company through a fragile stretch: stretching the cash runway into 2027, deepening the PIF and Uber partnerships, and prepping a robotaxi-ready Midsize platform. In April 2026 Lucid named Schindler veteran Silvio Napoli as permanent CEO; Winterhoff will return to the COO role.

Dinesh V. Patel, Ph.D. is the President and CEO of Protagonist Therapeutics (NASDAQ: PTGX), a Newark, California-based biopharmaceutical company he has led since December 2008. With over 38 years spanning medicinal chemistry, drug discovery, venture capital co-founding, and three CEO stints, Patel has guided Protagonist from a peptide-platform startup to a company with its first FDA-approved drug - ICOTYDE (icotrokinra), approved March 2026 as the world's first targeted oral peptide for moderate-to-severe plaque psoriasis, partnered with Johnson & Johnson.